1. In Vivo
  2. >>Global Vision

Splits Over Data Protection Could Hamper EU Pharma Revision

 
• By Ian Schofield

The chances of reaching agreement on proposals to overhaul the EU pharma rules before the European Parliament elections in June 2024 are receding as disagreements emerge over key issues such as regulatory data protection and how to encourage antimicrobial R&D.  

divided opinions
• Source: Shutterstock

Lawmakers are gearing up for what could be a long and arduous debate over the European Commission’s proposals for revising the EU pharmaceutical legislation. The revision package, consisting of a draft regulation and a draft directive, is wide-ranging and covers a multitude of areas relating to pharmaceutical regulation. First published in April 2023, it was formally presented to the European Parliament in September.

The contentious nature of many of the proposals bodes ill for a smooth journey through the legislative machinery at the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Global Vision

More from In Vivo

Deals Shaping The Industry, May 2025

 
• By In Vivo Team

An interactive look at pharma, medtech and diagnostics deals made during May 2025. Data courtesy of Biomedtracker.

Podcast: Flagship’s Vision To Predict And Prevent Illness, With Raj Panjabi

 
• By David Wild

Flagship Pioneering senior partner Raj Panjabi discusses shifting health care from reactive treatment to AI-powered prediction and prevention of disease before symptoms emerge.

Rising Leaders 2025: Namrata Saroj On The Importance Of Authenticity In Ophthalmology

 
• By Sushmita Panda

Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.